Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Rigel Pharmaceuticals Q4 Sales $35.792M Beat $34.102M Estimate

Author: Benzinga Newsdesk | March 05, 2024 05:14pm
Rigel Pharmaceuticals (NASDAQ:RIGL) reported quarterly sales of $35.792 million which beat the analyst consensus estimate of $34.102 million by 4.96 percent. This is a 30.20 percent decrease over sales of $51.278 million the same period last year.

Posted In: RIGL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist